Keisuke Funaki
Papers
2
Total Citations
19
H-Index
2
About
Keisuke Funaki is a urologic surgeon and researcher whose work centers on refining robotic-assisted surgical techniques for kidney and prostate cancers. His primary contributions lie in optimizing perioperative outcomes and expanding the role of minimally invasive surgery for high-risk patients. In a highly cited 2021 study (15 citations), Funaki demonstrated that a low RENAL Nephrometry Score can reliably predict the absence of intraoperative collecting system entry during robot-assisted partial nephrectomy, potentially sparing patients from unnecessary ureteral catheter placement and reducing operative time. This practical, evidence-based insight directly improves patient comfort and surgical efficiency. Funaki has also explored the limits of monotherapy in very-high-risk prostate cancer, showing in a 2021 study (4 citations) that extended robot-assisted laparoscopic prostatectomy with extended lymph node dissection can achieve meaningful oncologic control without neoadjuvant or adjuvant therapy. By challenging established treatment paradigms, his work offers a less morbid alternative for select patients with aggressive disease. With a focused portfolio that balances technical refinement with patient-centered outcomes, Funaki is contributing to the evolution of precision, risk-adapted urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2